Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence cervical cancer development

American Journal of Cancer Research

Volumn 5, Issue 7, 2015, Pages 2301-2307

  Guo, Lanwei ^a,c   Wen, Juan ^b   Han, Jing ^b   Jiang, Jie ^b   Xie, Shuanghua ^a   Feng, Xiaoshuang ^a   Wei, Baojun ^a   Dai, Juncheng ^b   Zhang, Kai ^a   Qi, Jun ^a   Ma, Hongxia ^b   Shi, Jufang ^a   Ren, Jiansong ^a   Zhang, Yue ^a   Dai, Min ^a   Hu, Zhibin ^b   Li, Ni ^a  

^a CANCER HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cervical cancer; eQTLs; ZNRD1; ZNRD1 AS1

Indexed keywords

LONG UNTRANSLATED RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC RIBBON DOMAIN CONTAINING 1 PROTEIN;

ARTICLE; CHRONIC DISEASE; FAMILY HISTORY; GENE EXPRESSION; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; PARITY; POPULATION RESEARCH; PREMENOPAUSE; PREVALENCE; PROTEIN FUNCTION; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

EID: 85006219622     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ferlay J SI, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: Fr Int Agency Res Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 21/02/2015.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
3. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
4. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N and Bosch FX. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007; 7: 453-459.
5. Ho GY, Bierman R, Beardsley L, Chang CJ and Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428.
6. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E and Palefsky J. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132: 277-284.
7. Dalstein V, Riethmuller D, Pretet JL, Le Bail Carval K, Sautiere JL, Carbillet JP, Kantelip B, Schaal JP and Mougin C. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003; 106: 396-403.
8. Chen HT, Legault P, Glushka J, Omichinski JG and Scott RA. Structure of a (Cys3His) zinc ribbon, a ubiquitous motif in archaeal and eucaryal transcription. Protein Sci 2000; 9: 1743-1752.
9. Grishin NV. C-terminal domains of Escherichia coli topoisomerase I belong to the zinc-ribbon superfamily. J Mol Biol 2000; 299: 1165-1177.
10. Shiina T, Inoko H and Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 2004; 64: 631-649.
11. Fan W, Wang Z, Kyzysztof F, Prange C and Lennon G. A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class I region. Genomics 2000; 63: 139-141.
12. Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC and Cannon PM. Human hematopoietic stem/progenitor cells modified by zincfinger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010; 28: 839-847.
13. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, Antonarakis SE, Letvin NL, McMichael AJ, Haynes BF, Telenti A and Goldstein DB. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317: 944-947.
14. Ballana E, Senserrich J, Pauls E, Faner R, Mercader JM, Uyttebroeck F, Palou E, Mena MP, Grau E, Clotet B, Ruiz L, Telenti A, Ciuffi A and Este JA. ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression. Clin Infect Dis 2010; 50: 1022-1032.
15. Guo W, Zhao YP, Jiang YG, Wang RW, Hong L and Fan DM. ZNRD1 might mediate UV irradiation related DNA damage and repair in human esophageal cancer cells by regulation of ERCC1. Dis Esophagus 2008; 21: 730-736.
16. Hong L, Han Y, Shi R, Shao X, Sun L, Zhang Y, Huang D, Chen Z, Zhang G, Liang J, Hu S and Fan D. ZNRD1 gene suppresses cell proliferation through cell cycle arrest in G1 phase. Cancer Biol Ther 2005; 4: 60-64.
17. Hong L, Han Y, Li S, Yang J, Gong T, Li J, Zheng J, Zhang H, Zhao Q, Wu K and Fan D. Role of ZNRD1 (zinc ribbon domain-containing 1) in angiogenesis of leukaemia cells. Cell Biol Int 2011; 35: 321-324.
18. Tam OH, Aravin AA, Stein P, Girard A, Murchison EP, Cheloufi S, Hodges E, Anger M, Sachidanandam R, Schultz RM and Hannon GJ. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 2008; 453: 534-538.
19. Wilusz JE, Sunwoo H and Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23: 1494-1504.
20. Wurdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO and Krichevsky AM. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008; 14: 382-393.
21. Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M and Pritchard JK. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet 2008; 4: e1000214.
22. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, Beazley C, Ingle CE, Dunning M, Flicek P, Koller D, Montgomery S, Tavare S, Deloukas P and Dermitzakis ET. Population genomics of human gene expression. Nat Genet 2007; 39: 1217-1224.
23. Wen J, Liu Y, Liu J, Liu L, Song C, Han J, Zhu L, Wang C, Chen J, Zhai X, Shen H and Hu Z. Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development. Mol Carcinog 2014; [Epub ahead of print].
24. Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Qiao YL and Franceschi S. Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer 2006; 95: 1593-1597.
25. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Huang RD, Sun LX, Meijer CJ, Qiao YL and Franceschi S. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006; 95: 96-101.
26. Elfgren K, Kalantari M, Moberger B, Hagmar B and Dillner J. A population-based five-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol 2000; 183: 561-567.
27. Deligeoroglou E, Giannouli A, Athanasopoulos N, Karountzos V, Vatopoulou A, Dimopoulos K and Creatsas G. HPV infection: immunological aspects and their utility in future therapy. Infect Dis Obstet Gynecol 2013; 2013: 540850.
28. Jiang J, Li N, Shen Y, Liu J, Liu L, Du J, Lei Y, Wen Y, Yang L, Guo L, Zhang K, Qiang F, Wang S, Hu Z, Dai M and Shen H. Genetic variants in HLA-DP/DQ contribute to risk of cervical cancer: a two-stage study in Chinese women. Gynecol Oncol 2013; 129: 401-405.
29. Shi Y, Li L, Hu Z, Li S, Wang S, Liu J, Wu C, He L, Zhou J, Li Z, Hu T, Chen Y, Jia Y, Wang S, Wu L, Cheng X, Yang Z, Yang R, Li X, Huang K, Zhang Q, Zhou H, Tang F, Chen Z, Shen J, Jiang J, Ding H, Xing H, Zhang S, Qu P, Song X, Lin Z, Deng D, Xi L, Lv W, Han X, Tao G, Yan L, Han Z, Li Z, Miao X, Pan S, Shen Y, Wang H, Liu D, Gong E, Li Z, Zhou L, Luan X, Wang C, Song Q, Wu S, Xu H, Shen J, Qiang F, Ma G, Liu L, Chen X, Liu J, Wu J, Shen Y, Wen Y, Chu M, Yu J, Hu X, Fan Y, He H, Jiang Y, Lei Z, Liu C, Chen J, Zhang Y, Yi C, Chen S, Li W, Wang D, Wang Z, Di W, Shen K, Lin D, Shen H, Feng Y, Xie X and Ma D. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet 2013; 45: 918-922.
30. Chen D, Juko-Pecirep I, Hammer J, Ivansson E, Enroth S, Gustavsson I, Feuk L, Magnusson PK, McKay JD, Wilander E and Gyllensten U. Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst 2013; 105: 624-633.
31. Peng RQ, Wan HY, Li HF, Liu M, Li X and Tang H. MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem 2012; 287: 14301-14309.